ESTA
NASDAQ HealthcareEstablishment Labs Holdings Inc.
$69.55
$0.22 (+0.32%)
Live quote
52w: $36.53 – $97.59
Loading chart…
P/E Ratio—
P/B Ratio95.62
EV/EBITDA—
Debt/Equity—
ROE-236.33%
ROIC—
Revenue Growth27.14%
Gross Margin69.32%
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Own ESTA? Track it here.
Create a free account to add ESTA to a portfolio and watch your P/L update in real time.
Custom screens, valuation models and backtesting are coming to Pro.